Clinical trial
Atrial Fibrillation Recurrence Following Cardioversion: the Role of Clinical Factors and Alpha Defensin Levels
NCT04155879 is registered in ClinicalTrials.gov with Hillel Yaffe Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Atrial Fibrillation Recurrence Following Cardioversion: the Role of Clinical Factors and Alpha Defensin Levels
- Lead sponsor
- Hillel Yaffe Medical Center
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 30, 2019
- Completion date
- November 30, 2022
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.